98 related articles for article (PubMed ID: 18477981)
1. [The association study of the DRD2 gene C939T polymorphism and schizophrenia.].
Monakhov MV; Golimbet VE; Chubabriia KV; Zykov VV; Kovtun AL; Karpov VL
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(10):58-60. PubMed ID: 18477981
[TBL] [Abstract][Full Text] [Related]
2. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
[TBL] [Abstract][Full Text] [Related]
3. Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population.
Monakhov M; Golimbet V; Abramova L; Kaleda V; Karpov V
Schizophr Res; 2008 Mar; 100(1-3):302-7. PubMed ID: 18255274
[TBL] [Abstract][Full Text] [Related]
4. The relationship between DRD2 gene polymorphisms (C957T and C939T) and schizophrenia: a meta-analysis.
Liu L; Fan D; Ding N; Hu Y; Cai G; Wang L; Xin L; Xia Q; Li X; Xu S; Xu J; Yang X; Zou Y; Pan F
Neurosci Lett; 2014 Nov; 583():43-8. PubMed ID: 25240594
[TBL] [Abstract][Full Text] [Related]
5. Support for an association of the C939T polymorphism in the human DRD2 gene with tardive dyskinesia in schizophrenia.
Mo GH; Lai IC; Wang YC; Chen JY; Lin CY; Chen TT; Chen ML; Liou YJ; Liao DL; Bai YM; Lin CC
Schizophr Res; 2007 Dec; 97(1-3):302-4. PubMed ID: 17669630
[No Abstract] [Full Text] [Related]
6. Association between Ser311Cys polymorphism in the dopamine D2 receptor gene and schizophrenia risk: a meta-analysis in Asian populations.
Liu ZW; Liu JL; An Y; Zhang L; Wang YM
Genet Mol Res; 2012 Feb; 11(1):261-70. PubMed ID: 22370928
[TBL] [Abstract][Full Text] [Related]
7. A novel DRD2 single-nucleotide polymorphism associated with schizophrenia predicts age of onset: HapMap tag-single-nucleotide polymorphism analysis.
Voisey J; Swagell CD; Hughes IP; Lawford BR; Young RM; Morris CP
Genet Test Mol Biomarkers; 2012 Feb; 16(2):77-81. PubMed ID: 21861710
[TBL] [Abstract][Full Text] [Related]
8. C957T DRD2 polymorphism is associated with schizophrenia in Spanish patients.
Hoenicka J; Aragüés M; Rodríguez-Jiménez R; Ponce G; Martínez I; Rubio G; Jiménez-Arriero MA; Palomo T;
Acta Psychiatr Scand; 2006 Dec; 114(6):435-8. PubMed ID: 17087792
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
[TBL] [Abstract][Full Text] [Related]
10. An association study of DRD2 gene polymorphisms with schizophrenia in a Chinese Han population.
Fan H; Zhang F; Xu Y; Huang X; Sun G; Song Y; Long H; Liu P
Neurosci Lett; 2010 Jun; 477(2):53-6. PubMed ID: 19913597
[TBL] [Abstract][Full Text] [Related]
11. An association study of dopaminergic (DRD2) and serotoninergic (5-HT2) gene polymorphism and schizophrenia in a North Indian population.
Kaur G; Singh Chavan B; Gupta D; Sinhmar V; Prasad R; Tripathi A; Garg PD; Gupta R; Khurana H; Gautam S; Margoob MA; Aneja J
Asian J Psychiatr; 2019 Jan; 39():178-184. PubMed ID: 30389402
[TBL] [Abstract][Full Text] [Related]
12. Association between the C957T polymorphism of the dopamine D2 receptor gene and schizophrenia.
Hänninen K; Katila H; Kampman O; Anttila S; Illi A; Rontu R; Mattila KM; Hietala J; Hurme M; Leinonen E; Lehtimäki T
Neurosci Lett; 2006 Oct; 407(3):195-8. PubMed ID: 16973280
[TBL] [Abstract][Full Text] [Related]
13. Association of DRD2 gene variant with schizophrenia.
Kukreti R; Tripathi S; Bhatnagar P; Gupta S; Chauhan C; Kubendran S; Janardhan Reddy YC; Jain S; Brahmachari SK
Neurosci Lett; 2006 Jan; 392(1-2):68-71. PubMed ID: 16183199
[TBL] [Abstract][Full Text] [Related]
14. Association between three functional polymorphisms of the dopamine D2 receptor gene and polydipsia in schizophrenia.
Matsumoto C; Shinkai T; De Luca V; Hwang R; Hori H; Lanktree M; Ohmori O; Kennedy JL; Nakamura J
Int J Neuropsychopharmacol; 2005 Jun; 8(2):245-53. PubMed ID: 15850500
[TBL] [Abstract][Full Text] [Related]
15. A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes.
Dubertret C; Bardel C; Ramoz N; Martin PM; Deybach JC; Adès J; Gorwood P; Gouya L
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):492-9. PubMed ID: 20138949
[TBL] [Abstract][Full Text] [Related]
16. Association and linkage disequilibrium between a functional polymorphism of the dopamine-2 receptor gene and schizophrenia in a genetically homogeneous Portuguese population.
Schindler KM; Pato MT; Dourado A; Macedo A; Azevedo MH; Kennedy JL; Pato CN
Mol Psychiatry; 2002; 7(9):1002-5. PubMed ID: 12399954
[TBL] [Abstract][Full Text] [Related]
17. A Novel Variant in Dopamine Receptor Type 2 Gene is Associated with Schizophrenia.
Hanif F; Amir QU; Washdev W; Bilwani F; Simjee SU; Haque Z
Arch Med Res; 2021 Apr; 52(3):348-353. PubMed ID: 33187731
[TBL] [Abstract][Full Text] [Related]
18. Rs1076560, a functional variant of the dopamine D2 receptor gene, confers risk of schizophrenia in Han Chinese.
Zheng C; Shen Y; Xu Q
Neurosci Lett; 2012 Jun; 518(1):41-4. PubMed ID: 22569179
[TBL] [Abstract][Full Text] [Related]
19. The DRD2 gene 957C>T polymorphism is associated with posttraumatic stress disorder in war veterans.
Voisey J; Swagell CD; Hughes IP; Morris CP; van Daal A; Noble EP; Kann B; Heslop KA; Young RM; Lawford BR
Depress Anxiety; 2009; 26(1):28-33. PubMed ID: 18833581
[TBL] [Abstract][Full Text] [Related]
20. [Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia].
Paweł K; Hauser J; Skibińska M; Szczepankiewicz A; Dmitrzak-Weglarz M; Gorzkowska K; Pawlak J; Czerski PM
Psychiatr Pol; 2010; 44(3):405-13. PubMed ID: 20672519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
